(Q38176321)

English

Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies

scientific article published on January 1986

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies (English)

1 reference

Europe PubMed Central

30 August 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Scully LJ

1

1 reference

Europe PubMed Central

30 August 2017

Lever AM

2

1 reference

Europe PubMed Central

30 August 2017

Yap I

3

1 reference

Europe PubMed Central

30 August 2017

Pignatelli M

4

1 reference

Europe PubMed Central

30 August 2017

Thomas HC

5

1 reference

Europe PubMed Central

30 August 2017

publication date

1 January 1986

1 reference

Europe PubMed Central

30 August 2017

Journal of Hepatology

1 reference

Europe PubMed Central

30 August 2017

3 Suppl 2

1 reference

Europe PubMed Central

30 August 2017

S291-9

1 reference

Europe PubMed Central

30 August 2017

Effect of Vidarabine on Chronic Hepatitis B Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of sexual preference and chronic hepatitis B virus infection on T lymphocyte subsets, natural killer activity, and suppressor cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral therapy in hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches to the treatment of hepatitis B virus and delta-related liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Homology between HBV-DNA and a sequence regulating the interferon-induced antiviral system: possible mechanism of persistent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980134-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(86)80134-9

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38176321&oldid=1745936727"